HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

cAMP/PKA-induced filamin A (FLNA) phosphorylation inhibits SST2 signal transduction in GH-secreting pituitary tumor cells.

Abstract
An efficient intracellular response to somatostatin analogs (SSA) in pituitary tumors requires filamin A (FLNA). Since cAMP pathway plays an important role in GH-secreting pituitary tumors pathogenesis and FLNA is phosphorylated by PKA on S2152, aim of this study was to investigate in tumoral somatotrophs the impact of cAMP pathway activation and SSA stimulation on FLNA phosphorylation and the consequences on SST2 function. We found a PKA-mediated increase (2-fold) and SST2 agonist-induced decrease (-50%) of FLNA phosphorylation in GH3, GH4C1 and primary somatotroph tumor cells. This modification regulates FLNA function. Indeed, phosphomimetic S2152D FLNA mutant, but not phosphodeficient S2152A, abolished the known SSA antitumoral effects, namely: 1) inhibition of cell proliferation, reduction of cyclin D3 and increase of p27; 2) increase of cell apoptosis; 3) inhibition of cell migration via RhoA activation and cofilin phosphorylation. Coimmunoprecipitation and immunofluorescence assays showed that S2152A FLNA was recruited to activated SST2, whereas S2152D FLNA constitutively bound SST2 on the plasma membrane, but prevented Gαi proteins recruitment to SST2. In conclusion, we demonstrated that FLNA phosphorylation, promoted by cAMP pathway activation and inhibited by SSA, prevented SST2 signaling in GH-secreting tumoral pituitary cells.
AuthorsE Peverelli, E Giardino, F Mangili, D Treppiedi, R Catalano, E Ferrante, E Sala, M Locatelli, A G Lania, M Arosio, A Spada, G Mantovani
JournalCancer letters (Cancer Lett) Vol. 435 Pg. 101-109 (10 28 2018) ISSN: 1872-7980 [Electronic] Ireland
PMID30098401 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2018 Elsevier B.V. All rights reserved.
Chemical References
  • FLNA protein, human
  • Filamins
  • Hormones
  • Receptors, Somatostatin
  • Somatostatin
  • somatostatin receptor 2
  • Cyclic AMP
  • Protein Kinases
Topics
  • Animals
  • Apoptosis (drug effects)
  • Cell Line, Tumor
  • Cell Movement (drug effects)
  • Cell Proliferation (drug effects)
  • Cyclic AMP (metabolism)
  • Filamins (metabolism)
  • Growth Hormone-Secreting Pituitary Adenoma (genetics, metabolism, pathology)
  • Hormones (pharmacology)
  • Humans
  • Phosphorylation (drug effects)
  • Pituitary Neoplasms (genetics, metabolism, pathology)
  • Protein Kinases (metabolism)
  • Rats
  • Receptors, Somatostatin (metabolism)
  • Signal Transduction (drug effects)
  • Somatostatin (pharmacology)
  • Somatotrophs (drug effects, metabolism)
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: